Skip to main content

So, everyone's going to get Libre on prescription on 1st November?!

In short, they're not. Nobody has them on prescription yet (edit 03/11/17 - almost nobody - there is some evidence that a few people might have them, but yet to be totally convinced). There are a small number that have persuaded their doctor/specialist to fund, but it's difficult to know exact circumstances and it hasn't been done in a coherent way.

The situation became different from 1st November, in that it is now possible to prescribe the Libre. However, the budgets are controlled by the local health authority (CCG) and ultimately they decide whether to fund or not and who to fund it for. There could be a chance that a GP/Specialist could go 'maverick' and prescribe without authority...but like current funding, will be rare and not coherently managed.

The problem the CCG have is two-fold. Firstly, budgets run from April to April. Starting funding in November means that they'll have to find extra cash from somewhere to fund the Libre - at least initially, it is going to cost more.

Secondly, and perhaps more importantly, there's not guidance from NICE about who should receive the Libre on prescription. There is limited health economic data and only a few large-scale trials.  Cost-effectiveness is yet to be proven any more than anecdotally.

As patients, our best bet for getting coherent funding of Libre is through patient groups like JDRF, Diabetes UK and Input. Rest assured they are working very hard to make Libre accessible to as many of the people that really need it as possible.

Speaking to doctors etc. may increase awareness, but as for funding across a wide area, the patient groups are the ones that are likely to make the biggest difference.

This information is gathered from my reading and speaking to interested parties, so if anyone has any other evidence or info, please share.

These two articles help:
http://www.inputdiabetes.org.uk/cgm/libre/ and http://www.inputdiabetes.org.uk/2017/10/access-flash/

Comments

PhilT said…
The case for NHS funding isn't black & white. Current user experiences are dominated by self selecting motivated users willing to fund themselves. The experiences of users on "free trials" or where NHS clinics apply the sensor to patients seem less clear cut.

The people with worst BG control are probably in denial or in some way impaired from getting on top of it, the Libre can give extra data but that doesn't help the data challenged.
3 November 2017 at 08:09
Post a Comment

Popular posts from this blog

First Post

This is my first post on a blog. Not sure whether it will be the last, but we'll see. I'm not sure I'm keen on sharing too much via a blog. I think work is out of bounds and not sure I want to share too much family stuff, but maybe I'll use it to record certain events. Most probably I will use it to record my experiences with diabetes. I was diagnosed yesterday with Type 1 (insulin dependent) diabetes. I am terrified (probably phobic, although I think it is an overused term) of needles, and know little about diabetes. Evidently my blood glucose was 37mmol/l when a normal reading is less than 10mmol/l. I guess the writing was on the wall. I have lost weight and had great thirst even though I ate lots of stuff and drank almost throughout the day. It is going to be an interesting few weeks finding out about the condition and dealing with the inevitable hardships that may follow. I even managed to eat Weetabix this morning without sugar for the first time in my life! I'...
2 comments
Read more

The CCG Project!

In order to find out the situation around the country for Libre prescribing now that the national policy has been published, I have made the decision to contact many of them to find out their plans.  I have arbitrarily chosen to contact all English CCGs that in December 2018 prescribed Libre via Primary Care to less than 5% of their population (and one specific request from a group member).  I had hoped this would be a small list, but there are 135 CCGs on the list.  I may have bitten off more than I can chew, but I'm committed to doing this and feeding back.  It worked before and hopefully this level of scrutiny will bring similar results. Below is a screenshot of the base document I am sending to each of the CCGs - it has some fields that are merge fields, so don't worry about the brackets and codes in the document (I found a typo, which has now been corrected too) .  The major piece of work with respect to this is finding the right person to contact....
9 comments
Read more

Abbott dX Virtual 2020

Having missed the preceding event in 2019 (in Lisbon) through my man meets horse moment, I was greatly looking forward to ‘attending’ this year’s event, albeit from my spare room rather than the rather more appealing Portuguese capital…but at least the quality of tea on offer was top-notch! Each year since 2015, Abbott have run an event for bloggers and influencers (and me!) bringing together representatives from all over Europe.   This year there were over forty representatives from fifteen European countries, including eight people from the UK.   The programme was split over Friday evening and Saturday morning with a variety of speakers and discussion sessions.   The sessions were run on the Remo platform ( https://remo.co/ ), an application I didn’t know of previously, but certainly something that has great potential.   I’ll go through its functionality at the end of my review. At this point I need to stress that I haven’t been asked to blog about this event a...
Post a Comment
Read more